ArticleArchives of medical science : AMS2021

Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia.

Quanfu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.